Author

L. Madaro

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

P. L. Puri· 2 shared A. B. Moeller· 1 shared C. Comert· 1 shared C. Nicoletti· 1 shared D. Proietti· 1 shared E. Groppa· 1 shared F. de Paoli· 1 shared F. M. V. Rossi· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

P. L. Puri

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

scRNA-seq-based analysis of skeletal muscle response to denervation reveals selective activation of muscle-resident glial cells and fibroblasts

C. Nicoletti, X. Wei, U. Etxaniz, D. Proietti, L. Madaro, P. L. Puri

This study uses scRNA-seq to analyze skeletal muscle response to denervation, finding selective activation of muscle-resident glial cells and fibroblasts, and their role in NMJ repair and fibrosis.

bioRxiv · Dec 29, 2020 · PreprintCell Biology

Human skeletal muscle CD90+ fibro-adipogenic progenitors are associated with muscle degeneration in type 2 diabetes patients

J. Farup, J. Just, F. de Paoli, L. Lin, J. B. Jensen, T. Billeskov, I. S. Roman, C. Comert, A. B. Moeller, L. Madaro, E. Groppa, R. G. Fred, U. Kampmann, S. B. Pedersen, P. Bross, , N. Jessen

This study identifies CD90+ fibro-adipogenic progenitors in T2DM skeletal muscle and shows PDGF signaling drives their pathogenic behavior, which is mitigated by Metformin.

bioRxiv · Aug 25, 2020Cell Biology